Effects of NAD3 Supplementation on Biomarkers of Aging

Completed · Not applicable · Has a placebo group

Conditions studied: Aging

In brief

This is a randomized, parallel-group, placebo-controlled, clinical trial in middle-aged and older male and female subjects from Ohio. Subjects will take an over-the-counter dietary supplement or a placebo for 12 weeks. Outcome measures will include body weight, systolic and diastolic blood pressure, standard blood chemistries (e.g. chemistry panel, lipid panel, CBC with differential), changes in mood, vitality, energy, fatigue, productivity, digestive wellness (via anchored Visual Analogue Scales).

Key facts

Study ID
NCT04276948
Run by
The Center for Applied Health Sciences, LLC
People needed
45
Starts
2020-06-08
Expected to finish
2021-05-30
Last updated by the study team
2022-11-14

Who can join

Age: 40 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.